Similar articles

• [Synthesis of aryloxypropanolamines with chromone or coumarin structures. Study of beta-blocking activity].

  Gesquière JC, Dhaisne JM, Marcinal-Lefebvre A, Bar D, Vincent A, Dupuis B. Gesquière JC, et al. Ann Pharm Fr. 1982 Sep;40(3):251-7. Ann Pharm Fr. 1982. PMID: 6129826 French. No abstract available.
• Studies on cardiovascular drugs. 5. 1-Amino-3-phenoxy-2-propanol derivatives as -adrenergic blocking agents.

  Nakanishi M, Muro T, Chihara Y, Imamura H, Nakao T. Nakanishi M, et al. J Med Chem. 1972 Jan;15(1):45-8. doi: 10.1021/jm00271a013. J Med Chem. 1972. PMID: 4399806 No abstract available.
• -Adrenergic blocking agents of the chromone and xanthone groups. II. Propranolol type derivatives.

  Da Re P, Primofiore GP, Bertelli A. Da Re P, et al. J Med Chem. 1972 Aug;15(8):868-9. doi: 10.1021/jm00278a029. J Med Chem. 1972. PMID: 4402954 No abstract available.
• [Contribution to the pharmacology of the beta-adrenolytics].

  Wagner J. Wagner J. Dtsch Med Wochenschr. 1970 Nov 27;95(48):2442-8. doi: 10.1055/s-0028-1108853. Dtsch Med Wochenschr. 1970. PMID: 4394708 Review. German. No abstract available.
• [Clinical pharmacology of beta adrenergic blocking agents].

  Toyama S, Suzuki K. Toyama S, et al. Nihon Rinsho. 1973 Sep;31(9):2687-95. Nihon Rinsho. 1973. PMID: 4148964 Review. Japanese. No abstract available.